Try

Relay Therapeutics, Inc.

RLAYUnited States

24 filed reports · 280 financial concepts · 0 earnings calls · 0 media appearances

Filed reports

24 reports · Jun 2020 to Jun 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR181,803Jun 2020 to Jun 2026
Annual · 10-KSEC EDGAR61,745Dec 2020 to Dec 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q210-QJun 30, 2026Aug 6, 2026209Open
FY2026 Q110-QMar 31, 2026May 5, 2026107Open
FY202510-KDec 31, 2025Feb 26, 2026514Open
FY2025 Q310-QSep 30, 2025Nov 6, 2025141Open
FY2025 Q110-QMar 31, 2025May 5, 202582Open
FY202410-KDec 31, 2024Feb 26, 2025240Open
FY2024 Q310-QSep 30, 2024Nov 6, 2024106Open
FY2024 Q210-QJun 30, 2024Aug 6, 2024119Open
FY2024 Q110-QMar 31, 2024May 2, 202484Open
FY202310-KDec 31, 2023Feb 22, 2024274Open
FY2023 Q310-QSep 30, 2023Nov 2, 2023106Open
FY2023 Q210-QJun 30, 2023Aug 8, 202385Open

Financial data

280 concepts · 3,548 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial277 concepts · 3,499 facts · Mar 2019 to Jul 2026

  • Adjustments to additional paid in capital sharebased compensation requisite service period recognition value37 · Mar 2019 to Jun 2026
  • Net income loss37 · Mar 2019 to Jun 2026
  • Stockholders equity (US GAAP)37 · Mar 2019 to Jun 2026
  • Cash and cash equivalents at carrying value36 · Jun 2019 to Jun 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents36 · Jun 2019 to Jun 2026
  • Comprehensive income net of tax36 · Jun 2019 to Jun 2026
  • General and administrative expense (US GAAP)36 · Jun 2019 to Jun 2026
  • Interest income other36 · Jun 2019 to Jun 2026
  • Operating expenses (US GAAP)36 · Jun 2019 to Jun 2026
  • Operating income loss36 · Jun 2019 to Jun 2026
  • Other comprehensive income loss net of tax36 · Jun 2019 to Jun 2026
  • Other comprehensive income unrealized holding gain loss on securities arising during period before tax36 · Jun 2019 to Jun 2026
  • Other nonoperating income expense36 · Jun 2019 to Jun 2026
  • Restricted cash36 · Jun 2019 to Jun 2026
  • Accretion amortization of discounts and premiums investments35 · Sep 2019 to Jun 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect35 · Sep 2019 to Jun 2026
  • Depreciation35 · Sep 2019 to Jun 2026
  • Increase decrease in prepaid expense35 · Sep 2019 to Jun 2026
  • Net cash provided by used in investing activities35 · Sep 2019 to Jun 2026
  • Net cash provided by used in operating activities35 · Sep 2019 to Jun 2026
  • Payments to acquire investments35 · Sep 2019 to Jun 2026
  • Proceeds from sale and maturity of other investments35 · Sep 2019 to Jun 2026
  • Share based compensation35 · Sep 2019 to Jun 2026
  • Stock issued during period value stock options exercised34 · Mar 2019 to Jun 2026

Geography3 concepts · 49 facts · Dec 2019 to Dec 2025

  • Operating lease payments26 · Dec 2019 to Dec 2025
  • Operating lease cost20 · Dec 2019 to Dec 2025
  • 399 Binney Street3 · Jun 2025 to Dec 2025

Segments

49 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement geographical3 members · 49 facts

  • Binney Street Cambridge Massachusetts25 · Dec 2019 to Dec 2025
  • Hampshire Street Cambridge Massachusetts16 · Dec 2020 to Dec 2025
  • One Kendall Square Cambridge MA8 · Dec 2023 to Dec 2025

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Relay Therapeutics, Inc. (RLAY) data · FactIQ